ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 70 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,630,558 | +126.1% | 962,694 | +167.4% | 4.50% | +233.2% |
Q3 2022 | $2,048,000 | -74.5% | 360,000 | -3.6% | 1.35% | -32.1% |
Q2 2021 | $8,018,000 | -85.6% | 373,288 | -58.7% | 1.99% | -81.4% |
Q1 2021 | $55,803,000 | +31.4% | 903,688 | -11.1% | 10.70% | +47.0% |
Q4 2020 | $42,477,000 | – | 1,016,688 | – | 7.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
CM Management, LLC | 275,000 | $825,000 | 0.88% |
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
Diametric Capital, LP | 200,000 | $600,000 | 0.25% |